


{"id":54423,"date":"2025-03-17T10:49:15","date_gmt":"2025-03-17T08:49:15","guid":{"rendered":"https:\/\/www.fyb.de\/shs-capital-and-co-investors-sell-selfapy-to-medice\/"},"modified":"2025-03-17T13:49:15","modified_gmt":"2025-03-17T11:49:15","slug":"shs-capital-and-co-investors-sell-selfapy-to-medice","status":"publish","type":"post","link":"https:\/\/www.fyb.de\/en\/shs-capital-and-co-investors-sell-selfapy-to-medice\/","title":{"rendered":"SHS Capital and co-investors sell SELFAPY to MEDICE"},"content":{"rendered":"<p>T\u00fcbin\u00adgen \u2014 Selfapy GmbH, a digi\u00adtal health pioneer for mental illness, has been acqui\u00adred by the MEDICE Health Family, the Euro\u00adpean market leader in the treat\u00adment of ADHD. As part of the tran\u00adsac\u00adtion, inves\u00adtors SHS Capi\u00adtal, Think.Health Ventures, IBB Ventures and HTGF sold their shares.&nbsp;<\/p>\n<p>Selfa\u00adpy\u2019s CE-certi\u00adfied medi\u00adcal devices offer flexi\u00adble and <em>quickly acces\u00adsi\u00adble online therapy programs<\/em> for people with mental illnesses such as depres\u00adsion, gene\u00adra\u00adli\u00adzed anxiety disor\u00adder, buli\u00admia nervosa, binge eating disor\u00adder and chro\u00adnic pain. The programs are available as an app on smart\u00adphones and tablets and can be prescri\u00adbed by doctors or psychotherapists.&nbsp;<\/p>\n<p>The acqui\u00adsi\u00adtion of Selfapy is another important step for the MEDICE Health Family on its way from a pure phar\u00admaceu\u00adti\u00adcal manu\u00adfac\u00adtu\u00adrer to a provi\u00adder of clini\u00adcally vali\u00adda\u00adted, multi\u00admo\u00addal health\u00adcare solu\u00adti\u00adons combi\u00adning phar\u00admaceu\u00adti\u00adcals, digi\u00adtal solu\u00adti\u00adons and nutri\u00adtio\u00adnal concepts.<\/p>\n<p>\u201cWe want to take even more compre\u00adhen\u00adsive care of pati\u00adents while also keeping an eye on current chal\u00adlenges in the health\u00adcare system. This is why we have been expan\u00adding our strong core in the phar\u00admaceu\u00adti\u00adcal busi\u00adness for seve\u00adral years to include deve\u00adlo\u00adp\u00adments in the field of digi\u00adtal health\u00adcare solu\u00adti\u00adons,\u201d says <strong>Dr. Katja P\u00fctter-Ammer, Mana\u00adging Part\u00adner of MEDICE<\/strong>, explai\u00adning the stra\u00adtegy of the family-run company.<\/p>\n<p>\u201cSelfapy alre\u00adady accounts for 20% of all perma\u00adnently listed DiGAs in the mental health sector. By joining forces with MEDICE and their strong ties to doctors and psycho\u00adthe\u00adra\u00adpists, we can now work even more speci\u00adfi\u00adcally on reali\u00adzing our vision so that no one with a mental illness has to wait for help. Toge\u00adther, we want to take digi\u00adtal care to a new level and reach even more people faster and more effec\u00adtively,\u201d says <strong>Selfapy Mana\u00adging Direc\u00adtor and CEO Adham Kassab<\/strong>.<\/p>\n<p><strong>Dr. Corne\u00adlius Maas, Part\u00adner at SHS Capi\u00adtal<\/strong>, who served as Chair\u00adman of the Advi\u00adsory Board at Selfapy for many years, comm\u00adents on the tran\u00adsac\u00adtion as follows: \u201cWe are deligh\u00adted that we have been able to firmly estab\u00adlish Selfapy with its digi\u00adtal health appli\u00adca\u00adti\u00adons as an inno\u00adva\u00adtive form of treat\u00adment in the German health\u00adcare market in recent years. With MEDICE as a stra\u00adte\u00adgic buyer, we have found the perfect part\u00adner for the next deve\u00adlo\u00adp\u00adment phase of Selfapy and wish both compa\u00adnies contin\u00adued success together.\u201d<\/p>\n<p><strong>About SHS<\/strong><\/p>\n<p>\u201cBuil\u00adding Euro\u00adpean Health\u00adcare Cham\u00adpi\u00adons\u201d is the guiding prin\u00adci\u00adple of the T\u00fcbin\u00adgen-based inves\u00adtor SHS Capi\u00adtal. With this in mind, the inves\u00adtor specia\u00adli\u00adzing in health\u00adcare invest\u00adments finan\u00adces and deve\u00adlops its port\u00adfo\u00adlio compa\u00adnies. Since its foun\u00adda\u00adtion in 1993, the focus of its invest\u00adments has been on expan\u00adsion finan\u00adcing, share\u00adhol\u00adder chan\u00adges and succes\u00adsion situations.&nbsp;<\/p>\n<p>www.shs-capital.eu<\/p>\n","protected":false},"excerpt":{"rendered":"<p>T\u00fcbin\u00adgen \u2014 Selfapy GmbH, a digi\u00adtal health pioneer for mental illness, has been acqui\u00adred by the MEDICE Health Family, the Euro\u00adpean market leader in the treat\u00adment of ADHD. As part of the tran\u00adsac\u00adtion, inves\u00adtors SHS Capi\u00adtal, Think.Health Ventures, IBB Ventures and HTGF sold their shares.&nbsp; Selfa\u00adpy\u2019s CE-certi\u00ad\u00adfied medi\u00adcal devices offer flexi\u00adble and quickly acces\u00adsi\u00adble online&nbsp;[\u2026]<\/p>\n","protected":false},"author":2,"featured_media":54421,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[1366],"tags":[],"class_list":["post-54423","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>SHS Capital and co-investors sell SELFAPY to MEDICE - FYB Financial Yearbook<\/title>\n<meta name=\"description\" content=\"T\u00fcbingen - Selfapy GmbH, a digital health pioneer for mental illness, has been acquired by the MEDICE Health Family, the European market leader in the treatment of ADHD. As part of the transaction, investors SHS Capital, Think.Health Ventures, IBB Ventures and HTGF sold their shares.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.fyb.de\/en\/shs-capital-and-co-investors-sell-selfapy-to-medice\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SHS Capital and co-investors sell SELFAPY to MEDICE - FYB Financial Yearbook\" \/>\n<meta property=\"og:description\" content=\"T\u00fcbingen - Selfapy GmbH, a digital health pioneer for mental illness, has been acquired by the MEDICE Health Family, the European market leader in the treatment of ADHD. As part of the transaction, investors SHS Capital, Think.Health Ventures, IBB Ventures and HTGF sold their shares.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.fyb.de\/en\/shs-capital-and-co-investors-sell-selfapy-to-medice\/\" \/>\n<meta property=\"og:site_name\" content=\"FYB Financial Yearbook\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-17T08:49:15+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-17T11:49:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.fyb.de\/wp-content\/uploads\/2025\/03\/dr-cornelius-maas-shs-capital-shs-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"564\" \/>\n\t<meta property=\"og:image:height\" content=\"368\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Tatjana Anderer\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tatjana Anderer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.fyb.de\/en\/shs-capital-and-co-investors-sell-selfapy-to-medice\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/shs-capital-and-co-investors-sell-selfapy-to-medice\/\"},\"author\":{\"name\":\"Tatjana Anderer\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\"},\"headline\":\"SHS Capital and co-investors sell SELFAPY to MEDICE\",\"datePublished\":\"2025-03-17T08:49:15+00:00\",\"dateModified\":\"2025-03-17T11:49:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/shs-capital-and-co-investors-sell-selfapy-to-medice\/\"},\"wordCount\":425,\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/shs-capital-and-co-investors-sell-selfapy-to-medice\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2025\/03\/dr-cornelius-maas-shs-capital-shs-1.png\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.fyb.de\/en\/shs-capital-and-co-investors-sell-selfapy-to-medice\/\",\"url\":\"https:\/\/www.fyb.de\/en\/shs-capital-and-co-investors-sell-selfapy-to-medice\/\",\"name\":\"SHS Capital and co-investors sell SELFAPY to MEDICE - FYB Financial Yearbook\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/shs-capital-and-co-investors-sell-selfapy-to-medice\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/shs-capital-and-co-investors-sell-selfapy-to-medice\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2025\/03\/dr-cornelius-maas-shs-capital-shs-1.png\",\"datePublished\":\"2025-03-17T08:49:15+00:00\",\"dateModified\":\"2025-03-17T11:49:15+00:00\",\"description\":\"T\u00fcbingen - Selfapy GmbH, a digital health pioneer for mental illness, has been acquired by the MEDICE Health Family, the European market leader in the treatment of ADHD. As part of the transaction, investors SHS Capital, Think.Health Ventures, IBB Ventures and HTGF sold their shares.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.fyb.de\/en\/shs-capital-and-co-investors-sell-selfapy-to-medice\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.fyb.de\/en\/shs-capital-and-co-investors-sell-selfapy-to-medice\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/shs-capital-and-co-investors-sell-selfapy-to-medice\/#primaryimage\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2025\/03\/dr-cornelius-maas-shs-capital-shs-1.png\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2025\/03\/dr-cornelius-maas-shs-capital-shs-1.png\",\"width\":564,\"height\":368,\"caption\":\"Dr. Cornelius Maas, Partner bei SHS Capital in T\u00fcbingen (\u00a9 SHS)\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.fyb.de\/en\/shs-capital-and-co-investors-sell-selfapy-to-medice\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.fyb.de\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SHS Capital and co-investors sell SELFAPY to MEDICE\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.fyb.de\/en\/#website\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"name\":\"FYB Financial Yearbook\",\"description\":\"For Your Business\",\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.fyb.de\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\",\"name\":\"FYB Financial Yearbook\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"caption\":\"FYB Financial Yearbook\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\",\"name\":\"Tatjana Anderer\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"caption\":\"Tatjana Anderer\"},\"description\":\"Gr\u00fcnderin des FYB-Verlag\",\"sameAs\":[\"http:\/\/neu.fyb.de\"],\"url\":\"https:\/\/www.fyb.de\/en\/author\/tanderer\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SHS Capital and co-investors sell SELFAPY to MEDICE - FYB Financial Yearbook","description":"T\u00fcbingen - Selfapy GmbH, a digital health pioneer for mental illness, has been acquired by the MEDICE Health Family, the European market leader in the treatment of ADHD. As part of the transaction, investors SHS Capital, Think.Health Ventures, IBB Ventures and HTGF sold their shares.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.fyb.de\/en\/shs-capital-and-co-investors-sell-selfapy-to-medice\/","og_locale":"en_US","og_type":"article","og_title":"SHS Capital and co-investors sell SELFAPY to MEDICE - FYB Financial Yearbook","og_description":"T\u00fcbingen - Selfapy GmbH, a digital health pioneer for mental illness, has been acquired by the MEDICE Health Family, the European market leader in the treatment of ADHD. As part of the transaction, investors SHS Capital, Think.Health Ventures, IBB Ventures and HTGF sold their shares.","og_url":"https:\/\/www.fyb.de\/en\/shs-capital-and-co-investors-sell-selfapy-to-medice\/","og_site_name":"FYB Financial Yearbook","article_published_time":"2025-03-17T08:49:15+00:00","article_modified_time":"2025-03-17T11:49:15+00:00","og_image":[{"width":564,"height":368,"url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2025\/03\/dr-cornelius-maas-shs-capital-shs-1.png","type":"image\/png"}],"author":"Tatjana Anderer","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Tatjana Anderer","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.fyb.de\/en\/shs-capital-and-co-investors-sell-selfapy-to-medice\/#article","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/shs-capital-and-co-investors-sell-selfapy-to-medice\/"},"author":{"name":"Tatjana Anderer","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce"},"headline":"SHS Capital and co-investors sell SELFAPY to MEDICE","datePublished":"2025-03-17T08:49:15+00:00","dateModified":"2025-03-17T11:49:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.fyb.de\/en\/shs-capital-and-co-investors-sell-selfapy-to-medice\/"},"wordCount":425,"publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"image":{"@id":"https:\/\/www.fyb.de\/en\/shs-capital-and-co-investors-sell-selfapy-to-medice\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2025\/03\/dr-cornelius-maas-shs-capital-shs-1.png","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.fyb.de\/en\/shs-capital-and-co-investors-sell-selfapy-to-medice\/","url":"https:\/\/www.fyb.de\/en\/shs-capital-and-co-investors-sell-selfapy-to-medice\/","name":"SHS Capital and co-investors sell SELFAPY to MEDICE - FYB Financial Yearbook","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.fyb.de\/en\/shs-capital-and-co-investors-sell-selfapy-to-medice\/#primaryimage"},"image":{"@id":"https:\/\/www.fyb.de\/en\/shs-capital-and-co-investors-sell-selfapy-to-medice\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2025\/03\/dr-cornelius-maas-shs-capital-shs-1.png","datePublished":"2025-03-17T08:49:15+00:00","dateModified":"2025-03-17T11:49:15+00:00","description":"T\u00fcbingen - Selfapy GmbH, a digital health pioneer for mental illness, has been acquired by the MEDICE Health Family, the European market leader in the treatment of ADHD. As part of the transaction, investors SHS Capital, Think.Health Ventures, IBB Ventures and HTGF sold their shares.","breadcrumb":{"@id":"https:\/\/www.fyb.de\/en\/shs-capital-and-co-investors-sell-selfapy-to-medice\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.fyb.de\/en\/shs-capital-and-co-investors-sell-selfapy-to-medice\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/shs-capital-and-co-investors-sell-selfapy-to-medice\/#primaryimage","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2025\/03\/dr-cornelius-maas-shs-capital-shs-1.png","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2025\/03\/dr-cornelius-maas-shs-capital-shs-1.png","width":564,"height":368,"caption":"Dr. Cornelius Maas, Partner bei SHS Capital in T\u00fcbingen (\u00a9 SHS)"},{"@type":"BreadcrumbList","@id":"https:\/\/www.fyb.de\/en\/shs-capital-and-co-investors-sell-selfapy-to-medice\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.fyb.de\/en\/"},{"@type":"ListItem","position":2,"name":"SHS Capital and co-investors sell SELFAPY to MEDICE"}]},{"@type":"WebSite","@id":"https:\/\/www.fyb.de\/en\/#website","url":"https:\/\/www.fyb.de\/en\/","name":"FYB Financial Yearbook","description":"For Your Business","publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.fyb.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.fyb.de\/en\/#organization","name":"FYB Financial Yearbook","url":"https:\/\/www.fyb.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","caption":"FYB Financial Yearbook"},"image":{"@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce","name":"Tatjana Anderer","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","caption":"Tatjana Anderer"},"description":"Gr\u00fcnderin des FYB-Verlag","sameAs":["http:\/\/neu.fyb.de"],"url":"https:\/\/www.fyb.de\/en\/author\/tanderer\/"}]}},"_links":{"self":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/54423","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/comments?post=54423"}],"version-history":[{"count":0,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/54423\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media\/54421"}],"wp:attachment":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media?parent=54423"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/categories?post=54423"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/tags?post=54423"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}